Immunogenicity of the bivalent Oral Cholera vaccine shanchol in Haitian adults with HIV infection

Journal of Infectious Diseases

Volumn 212, Issue 5, 2015, Pages 779-783

  Ivers, Louise C ^a,b,d   Charles, Richelle C ^c,e   Hilaire, Isabelle J ^d   Mayo Smith, Leslie M ^e   Teng, Jessica E ^a,d   Jerome, J Gregory ^d   Rychert, Jenna ^e   LaRocque, Regina C ^c,e   Xu, Peng ^f   Kováč, Pavol ^f   Ryan, Edward T ^c,e   Qadri, Firdausi ^g   Almazor, Charles P ^d   Franke, Molly F ^b,d   Harris, Jason B ^c,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Department of Global Health and Social Medicine ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PARTNERS IN HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Cholera vaccine; HIV; Immunogenicity; Shanchol (BivWC)

Indexed keywords

CHOLERA VACCINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; IMMUNOGLOBULIN A; SHANCHOL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BACTERIAL STRAIN; CHOLERA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HAITIAN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROTYPE; SINGLE DRUG DOSE; VACCINATION; VIBRIO CHOLERAE; BLOOD; CD4 LYMPHOCYTE COUNT; COMPLICATION; HAITI; IMMUNOLOGY; MICROBIAL VIABILITY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; SERUM BACTERICIDAL ACTIVITY;

ADMINISTRATION, ORAL; ADULT; BLOOD BACTERICIDAL ACTIVITY; CD4 LYMPHOCYTE COUNT; CHOLERA; CHOLERA VACCINES; COHORT STUDIES; FEMALE; HAITI; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN A; MALE; MICROBIAL VIABILITY; MIDDLE AGED;

EID: 84943327389     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv108     Document Type: Article

References (12)

1. von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique. Trop Med Int Health 2008; 13:683-8.
2. Valcin CL, Severe K, Riche CT, et al. Predictors of disease severity in patients admitted to a cholera treatment center in urban Haiti. Am J Trop Med Hyg 2013; 89:625-32.
3. Lucas ME, Deen JL, von Seidlein L, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005; 352:757-67.
4. Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2013; 13:1050-6.
5. Perry RT, Plowe CV, Koumare B, et al. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ 1998; 76:63-71.
6. Charles RC, Hilaire IJ, Mayo-Smith LM, et al. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis 2014; 8:e2828.
7. Uddin T, Aktar A, Xu P, et al. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg 2014; 90: 873-81.
8. Troy SB, Musingwini G, Halpern MS, et al. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and-uninfected Zimbabwean infants. J Infect Dis 2013; 208:672-8.
9. Bliss SJ, O'Brien KL, Janoff EN, et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2008; 8:67-80.
10. Cayemittes M, Fatuma Busangu M, de Dieu Bizimana J, Barrère B, Sévère B, Cayemittes et Emmanuel Charles V. Enquête Mortalité, Morbidité et Utilisation des Services, Haïti, 2012. Calverton, MD: MSPP, IHE et ICF International, 2013.
11. Saha D, LaRocque RC, Khan AI, et al. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J Infect Dis 2004; 189:2318-22.
12. Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of sevenvalent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and-uninfected children in South Africa: a matched case-control study. Clin Infect Dis 2014; 59:808-18.